68001-510 : Fulvestrant 68001-510 50 mg/ml Intramuscular Injection
NDC: | 68001-510 |
Labeler: | Bluepoint Laboratories |
Product Type: | Human Prescription Drug |
Drug Name: | ![]() |
Dosage Form: | Intramuscular Injection |
Application #: | ANDA207754 |
Rev. Date: |
NDC Package Codes:
- 68001-510-85: 2 SYRINGE, GLASS IN 1 CARTON (68001‑510‑85) > 5 ML IN 1 SYRINGE, GLASS (68001‑510‑86)
Active Ingredients:
- Fulvestrant
Dosage Strength:
- 50 mg/mL
Pharmaceutical Classes:
- Estrogen Receptor Antagonist [EPC]
- Estrogen Receptor Antagonists [MoA]
- Selective Estrogen Receptor Modulators [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 68001-509Next: 68001-511 >
Related Discussions:
Fulvestrant and Belviqside
I have stage IV breast cancer. After being unable to control cancer with different endocrine therapy my oncologist put m... 1 reply
I have stage IV breast cancer. After being unable to control cancer with different endocrine therapy my oncologist put m... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.